Noxopharm Limited (NOXOF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | - AUD | 0.0% |
| 2023 | - AUD | 0.0% |
| 2022 | - AUD | -100.0% |
| 2021 | 117.64 Thousand AUD | -71.54% |
| 2020 | 413.29 Thousand AUD | 0.0% |
| 2019 | - AUD | -100.0% |
| 2018 | 3.27 Million AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q4 | - AUD | 0.0% |
| 2024 Q3 | - AUD | 0.0% |
| 2024 Q2 | - AUD | 0.0% |
| 2024 Q1 | - AUD | 0.0% |
| 2024 FY | - AUD | 0.0% |
| 2023 Q2 | - AUD | 0.0% |
| 2023 Q4 | - AUD | 0.0% |
| 2023 FY | - AUD | 0.0% |
| 2023 Q1 | - AUD | 0.0% |
| 2023 Q3 | - AUD | 0.0% |
| 2022 Q2 | 12.1 Thousand AUD | 0.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2022 FY | - AUD | -100.0% |
| 2022 Q1 | 12.1 Thousand AUD | -89.71% |
| 2022 Q3 | - AUD | -100.0% |
| 2021 Q1 | 244.25 Thousand AUD | -40.9% |
| 2021 FY | 117.64 Thousand AUD | -71.54% |
| 2021 Q4 | 117.64 Thousand AUD | 0.0% |
| 2021 Q3 | 117.64 Thousand AUD | -51.84% |
| 2021 Q2 | 244.25 Thousand AUD | 0.0% |
| 2020 Q1 | 3.89 Million AUD | 0.0% |
| 2020 Q3 | 413.29 Thousand AUD | -87.61% |
| 2020 Q2 | 3.33 Million AUD | -14.23% |
| 2020 FY | 413.29 Thousand AUD | 0.0% |
| 2020 Q4 | 413.29 Thousand AUD | 0.0% |
| 2019 Q1 | - AUD | -100.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q3 | - AUD | 0.0% |
| 2019 FY | - AUD | -100.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2018 Q3 | 3.27 Million AUD | 0.0% |
| 2018 FY | 3.27 Million AUD | 0.0% |
| 2018 Q1 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 Q4 | 3.27 Million AUD | 0.0% |
| 2017 Q1 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q3 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |